Seeking Alpha

Amgen (AMGN) CEO Kevin Sharer will retire in May and be replaced by company President and COO...

Amgen (AMGN) CEO Kevin Sharer will retire in May and be replaced by company President and COO Robert Bradway. RBC Capital analyst Michael Yee says the biotech's new CEO will need to "reinvigorate a focus of innovation for new products and a focus on cutting expenses." Are both those possible? (PR)
Comments (1)
  • User 509088
    , contributor
    Comments (1201) | Send Message
     
    yes! hire news of the world hacks to hack the phones of research teams of other co's.

     

    pressers work cheaper than phd's. theft has always been an innovative and cost effective way of finding new products.

     

    ha!
    16 Dec 2011, 07:17 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs